Which likely means we can continue to see
the IBB just continue to trade in place, in the $ 285 to $ 305 range.
First, let's take a look at the longer - term weekly chart, which shows that $
IBB just broke out above a valid base of consolidation last week:
Not exact matches
The iShares Nasdaq Biotechnology ETF (
IBB) hit a high of $ 300.29 Thursday, and closed at $ 300.08,
just below the $ 302.40 level hit in January.
Once you look at the group — using iShares Nasdaq Biotechnology ETF (
IBB) as a proxy, the performance is
just cosmetic.
Surprisingly,
IBB appears very radical in his «restructuring»: a Federal Government with powers over
just foreign policy, defence, and the economy, eerily close to the confederal arrangement the Emeka Ojukwu - led Eastern Region called for in 1967.